Εμφάνιση απλής εγγραφής

dc.creatorGalanis P., Kaitelidou D., Prezerakos P., Kotsiopoulos I., Siskou O., Konstantakopoulou O., Hadjichristodoulou C., Tsiodras S.en
dc.date.accessioned2023-01-31T07:39:30Z
dc.date.available2023-01-31T07:39:30Z
dc.date.issued2021
dc.identifier10.1016/j.puhe.2021.07.029
dc.identifier.issn00333506
dc.identifier.urihttp://hdl.handle.net/11615/71919
dc.description.abstractObjectives: To estimate the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity among healthcare workers (HCWs) in Greece and to identify high-risk groups in healthcare facilities. Study design: The study design used in this study is a nationwide cross-sectional study. Methods: Data were collected from 1 June to 9 July 2020. HCWs in the Greek National Health System were offered a free SARS-CoV-2 IgG antibody test, regardless of symptoms. Results: Overall, 379 of 57,418 HCWs (0.66%, 95% confidence interval [CI]: 0.59–0.73) were positive for SARS-CoV-2 antibodies. The adjusted overall seroprevalence was 0.43% (95% CI: 0.35–0.51). We found that HCWs in non-reference hospitals for COVID-19 (odds ratio [OR]: 1.81, 95% CI: 1.23–2.64; P = 0.002) and reference hospitals for COVID-19 (OR: 1.66, 95% CI: 1.06–2.58; P = 0.03) were more likely to be seropositive than HCWs in primary care centres. Regarding professions, nurses (OR: 1.45, 95% CI: 1.07–1.98; P = 0.02), physicians (OR: 1.43, 95% CI: 1.06–1.93; P = 0.02), and administrative, cleaning and security staff (OR: 1.50, 95% CI: 1.09–2.06; P = 0.01) had a statistically higher chance of having a positive serology than laboratory employees. Conclusions: The adjusted overall seroprevalence found in this study indicates a very low prevalence of SARS-CoV-2 among HCWs in Greece. This result is in line with the low incidence of COVID-19 during the first wave of the pandemic and is a direct benefit from the early implementation of lockdown. © 2021 The Royal Society for Public Healthen
dc.language.isoenen
dc.sourcePublic Healthen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85114150166&doi=10.1016%2fj.puhe.2021.07.029&partnerID=40&md5=959f5449d12f5c44d125099e9ecee97a
dc.subjectimmunoglobulin G antibodyen
dc.subjectSARS-CoV-2 antibodyen
dc.subjectantibodyen
dc.subjectCOVID-19en
dc.subjectepidemicen
dc.subjecthealth workeren
dc.subjecthospital sectoren
dc.subjectpandemicen
dc.subjectpathogenen
dc.subjectsevere acute respiratory syndromeen
dc.subjectadulten
dc.subjectArticleen
dc.subjectclinical laboratory personnelen
dc.subjectcontrolled studyen
dc.subjectcoronavirus disease 2019en
dc.subjectcross-sectional studyen
dc.subjectdisease associationen
dc.subjectfemaleen
dc.subjectGreeceen
dc.subjecthealth care personnelen
dc.subjecthigh risk populationen
dc.subjecthospital administratoren
dc.subjecthospital personnelen
dc.subjecthumanen
dc.subjectincidenceen
dc.subjectinfection risken
dc.subjectmaleen
dc.subjectnurseen
dc.subjectpandemicen
dc.subjectphysicianen
dc.subjectseroprevalenceen
dc.subjectSevere acute respiratory syndrome coronavirus 2en
dc.subjectcommunicable disease controlen
dc.subjectepidemiologyen
dc.subjecthealth care personnelen
dc.subjectpandemicen
dc.subjectseroepidemiologyen
dc.subjectGreeceen
dc.subjectSARS coronavirusen
dc.subjectCommunicable Disease Controlen
dc.subjectCOVID-19en
dc.subjectCross-Sectional Studiesen
dc.subjectGreeceen
dc.subjectHealth Personnelen
dc.subjectHumansen
dc.subjectPandemicsen
dc.subjectSARS-CoV-2en
dc.subjectSeroepidemiologic Studiesen
dc.subjectElsevier B.V.en
dc.titleLow seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greeceen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής